Fri, 22 Nov 2019

Markray Brings Unique Health Unit to the Market

ACCESSWIRE
23 Oct 2019, 01:19 GMT+10

GLENDALE, CA / ACCESSWIRE / October 22, 2019 / Markray Corporation (OTC PINK:RVBR), through its wholly owned subsidiary, Keshe Foundation Global, Inc. (KFGL), is pleased to announce its partnership with Keshe Foundation Manufacturing Austria GmbH (Keshe - Austria), to market and sell a new, Austrian, breakthrough health unit. The units is the first of a number of revolutionary, new technologies the company plans to present and release to government officials at various international conferences around the world. Initial conference has been held in Austria in September 2019 and few more are to follow in upcoming months in various Countries.

KFGL is one of only 3 Keshe worldwide companies to market for the CE certified, class one medical device called the Universal Body Enhancement Spaceship Unit.

Under the terms of the partnership with Keshe - Austria, KFGL has secured two promotional offer periods. The first, which closes on the 30th December 2019 is a give-away promotional price of just 150,000 (one hundred fifty thousand) Euros or approximately USD $165,000. Then, between January 1st and February 29th 2020, the price will increase to 500,000 Euros (approx. USD $550,000), before reaching its expected, regular market value of 1,000,000 (one million) Euros (approx. USD $1.1 million), per unit on the 1st of March 2020 and thereafter.

Universal Body Enhancement Spaceship Unit introduces a new paradigm in science. There is no medication or treatment. Instead, the unit produces magnetic and gravitational field forces inside a car-sized egg, in which a person sits or lies, while being overseen by a doctor. These field effects mimic the fields in the womb and allow the person's cells to process back to their original state with the result that the body once again functions as it should.

Initial orders for the first units with deposits have already been placed in advance of first deliveries due in January 2020. KFGL expects to generate additional orders internationally as word spreads, over the coming weeks and months.

To learn more, express interest and place orders, please go to:

.

About Markray Corporation

Markray Corporation is a development stage holding company targeting diversity and increased shareholder value through a series of acquisitions and mergers. It and it's subsidiaries hold the intellectual property and technical expertise to certain plasma technologies for the development and distribution of a wide variety of disruptive and novel technologies that it believes will create a new industrial revolution in market sectors including, but not limited to, agriculture and food security, animal husbandry, health and medicine, energy saving and energy production, pollution control and decontamination, materials production, land, sea and air transportation, communications technology and space travel and exploration. Subsidiaries of Markray Corporation are planning to partner with some of the largest corporations around the world to inject the new scientific understanding and advanced solutions into existing technologies, manufacturing facilities and production lines. The Company has a roadmap for global expansion, including international research and development and the creation of industrial zones specifically for raw materials production on every continent. It is that the plan of the Company to make Markray Corporation and its subsidiaries household names in the near future, as their technical know-how transforms many of our every-day points of reference from our homes and vehicles to our communications, food, and healthcare.

Safe Harbor and Informational Statement

This press release may contain forward-looking information, including all statements that are not statement of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial conditions or results of operations; (iii): the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends.

The words 'may,' 'would,' 'will,' 'expect,' 'estimate,' 'anticipate,' 'believe,' 'intend,' and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statement is not a guarantee of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the Company's statements and reports filed with the OTC Markets.

CONTACT:

MT Keshe
ir@kfgl.global

SOURCE: Markray Corporation



View source version on accesswire.com:
https://www.accesswire.com/563789/Markray-Brings-Unique-Health-Unit-to-the-Market

More Washington DC News

Access More

Sign up for Washington DC News

a daily newsletter full of things to discuss over drinks.and the great thing is that it's on the house!